Healthcare provider profile · identity verified

Heath A. Morgan, DO

Allopathic & Osteopathic Physicians|Internal Medicine · SPRINGFIELD, MO · NPI 1689733560

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Heath A. Morgan, DO received $54.93 in general payments during 2025 across 3 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 104 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 140 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 93 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$54.93

3 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$54.93	100.0%	3	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$54.93	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$37.35	2	2025
Source payment records 2025-03-12 · Lilly USA, LLC · $17.67 · Open Payments source 2025-06-02 · Lilly USA, LLC · $19.68 · Open Payments source
MOUNJARO Normalized: mounjaro	Drug	Lilly USA, LLC	$17.58	1	2025
Source payment records 2025-07-09 · Lilly USA, LLC · $17.58 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
MOUNJARO mounjaro	2025	Mounjaro	2024	140	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	104	25
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	140	19
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	93	14

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	843	238
Levothyroxine Sodium	Levothyroxine Sodium	592	155
Alprazolam	Alprazolam	483	78
Amlodipine Besylate	Amlodipine Besylate	457	125
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	440	96
Lisinopril	Lisinopril	415	118
Hydrochlorothiazide	Hydrochlorothiazide	413	120
Gabapentin	Gabapentin	371	86
Pantoprazole Sodium	Pantoprazole Sodium	367	104
Omeprazole	Omeprazole	361	92
Tramadol Hcl	Tramadol Hcl	330	75
Zolpidem Tartrate	Zolpidem Tartrate	310	43
Metoprolol Succinate	Metoprolol Succinate	309	85
Losartan Potassium	Losartan Potassium	274	77
Eliquis	Apixaban	271	52
Furosemide	Furosemide	257	77
Rosuvastatin Calcium	Rosuvastatin Calcium	253	72
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	242	62
Trazodone Hcl	Trazodone Hcl	236	66
Metformin Hcl	Metformin Hcl	222	62
Tizanidine Hcl	Tizanidine Hcl	212	57
Duloxetine Hcl	Duloxetine Hcl	208	42
Simvastatin	Simvastatin	199	57
Tamsulosin Hcl	Tamsulosin Hcl	199	60
Metoprolol Tartrate	Metoprolol Tartrate	190	59
Albuterol Sulfate Hfa	Albuterol Sulfate	181	63
Bupropion Hcl Sr	Bupropion Hcl	166	41
Sertraline Hcl	Sertraline Hcl	165	42
Prednisone	Prednisone	156	88
Meloxicam	Meloxicam	152	44
Lorazepam	Lorazepam	151	22
Potassium Chloride	Potassium Chloride	151	41
Carvedilol	Carvedilol	148	37
Allopurinol	Allopurinol	145	39
Mounjaro	Tirzepatide	140	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	131	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	131	28
Spironolactone	Spironolactone	125	28
Citalopram Hbr	Citalopram Hydrobromide	121	30
Clonazepam	Clonazepam	120	36
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	110	63
Clopidogrel	Clopidogrel Bisulfate	109	27
Famotidine	Famotidine	106	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	106	18
Alendronate Sodium	Alendronate Sodium	104	27
Jardiance	Empagliflozin	104	25
Pravastatin Sodium	Pravastatin Sodium	104	32
Glipizide	Glipizide	103	27
Glimepiride	Glimepiride	102	27
Escitalopram Oxalate	Escitalopram Oxalate	101	29
Propranolol Hcl	Propranolol Hcl	99	23
Fluticasone Propionate	Fluticasone Propionate	98	36
Montelukast Sodium	Montelukast Sodium	96	23
Ozempic	Semaglutide	95	18
Trulicity	Dulaglutide	93	14
Eszopiclone	Eszopiclone	92	21
Olmesartan Medoxomil	Olmesartan Medoxomil	92	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	89	25
Azithromycin	Azithromycin	84	72
Celecoxib	Celecoxib	79	25
Warfarin Sodium	Warfarin Sodium	79	22
Hydralazine Hcl	Hydralazine Hcl	78	20
Venlafaxine Hcl Er	Venlafaxine Hcl	75	17
Oxycodone Hcl	Oxycodone Hcl	73	13
Memantine Hcl	Memantine Hcl	69	15
Oxybutynin Chloride Er	Oxybutynin Chloride	69	20
Diclofenac Sodium	Diclofenac Sodium	68	13
Esomeprazole Magnesium	Esomeprazole Magnesium	68	18
Metformin Hcl Er	Metformin Hcl	66	20
Baclofen	Baclofen	63	13
Bupropion Xl	Bupropion Hcl	61	18
Lovastatin	Lovastatin	61	17
Ropinirole Hcl	Ropinirole Hcl	61	14
Doxazosin Mesylate	Doxazosin Mesylate	57	suppressed
Ezetimibe	Ezetimibe	57	14
Azelastine Hcl	Azelastine Hcl	56	24
Finasteride	Finasteride	56	17
Paroxetine Hcl	Paroxetine Hcl	56	14
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	54	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	14
Valacyclovir	Valacyclovir Hcl	54	22
Ibuprofen	Ibuprofen	53	16
Sumatriptan Succinate	Sumatriptan Succinate	53	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	52	18
Buspirone Hcl	Buspirone Hcl	52	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Atenolol	Atenolol	50	14
Estradiol	Estradiol	50	15
Pioglitazone Hcl	Pioglitazone Hcl	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	16
Naproxen	Naproxen	49	15
Ondansetron Hcl	Ondansetron Hcl	49	14
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	48	13
Ondansetron Odt	Ondansetron	47	21
Donepezil Hcl	Donepezil Hcl	46	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	45	11
Dicyclomine Hcl	Dicyclomine Hcl	45	15
Metolazone	Metolazone	44	16
Modafinil	Modafinil	44	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	44	suppressed
Irbesartan	Irbesartan	41	11
Morphine Sulfate Er	Morphine Sulfate	39	suppressed
Xarelto	Rivaroxaban	38	suppressed
Synthroid	Levothyroxine Sodium	37	13
Glyburide	Glyburide	36	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Pregabalin	Pregabalin	35	suppressed
Diazepam	Diazepam	34	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	34	suppressed
Solifenacin Succinate	Solifenacin Succinate	33	suppressed
Valsartan	Valsartan	33	12
Bumetanide	Bumetanide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	31	12
Dexamethasone	Dexamethasone	30	suppressed
Mirtazapine	Mirtazapine	30	11
Nifedipine Er	Nifedipine	30	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	29	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	14
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Klor-Con M20	Potassium Chloride	28	suppressed
Cephalexin	Cephalexin	27	13
Doxycycline Monohydrate	Doxycycline Monohydrate	27	25
Fenofibrate	Fenofibrate	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	26	suppressed
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Temazepam	Temazepam	26	suppressed
Tresiba Flextouch U-200	Insulin Degludec	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Guanfacine Hcl	Guanfacine Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Breyna	Budesonide/Formoterol Fumarate	20	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Rizatriptan	Rizatriptan Benzoate	20	suppressed
Digoxin	Digoxin	19	suppressed
Fluconazole	Fluconazole	19	11
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	15
Linzess	Linaclotide	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Clonidine	Clonidine	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	16	suppressed
Nystatin	Nystatin	16	14
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Cefadroxil	Cefadroxil	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	12
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Acyclovir	Acyclovir	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Dilt-Xr	Diltiazem Hcl	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Insulin Lispro Protamine Mix	Insulin Lispro Protamin/Lispro	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Movantik	Naloxegol Oxalate	12	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Jantoven	Warfarin Sodium	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$54.93 · 3 records	Lilly USA, LLC	MOUNJARO, ZEPBOUND	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Mounjaro play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error